TransCode Therapeutics Inc.
RNAZ | NASDAQ
$1.76
+$0.11 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.76
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:44 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -19.17B | -19.16B | -1.39B | -27.13M | -24.6M | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.55M | -19.59M | -18.58M | -18.91M | -17.56M | -15.23M | -13.27M | -5.83M | -6.84M | -4.85M | -3.89M | -6.79M |
Depreciation & Amortization | 17.6M | 17.61M | -6.27M | 192.25K | 314.99K | 444.39K | 534.86K | 552.18K | 563.44K | 558.19K | 516.75K | 406.08K | 292.1K | 177.2K | 98.61K | 98.09K | 80.82K | 62.82K | 42.47K | 13.48K | 5.95K | 1.26K |
Stock-Based Compensation | -95.71M | -95.71M | -95.55M | 326.5K | 530.98K | 530.98K | 373.25K | 204.48K | 392.33K | 567.82K | 726.58K | 857.13K | 570.4K | 493.52K | 395.33K | 303.77K | 198.17K | 99.57K | 87.43K | 61.1K | 92.48K | 93.18K |
Other Working Capital | -498.55K | 75.32K | 552.71K | 345.22K | 603.6K | 686.04K | 568.32K | -300.81K | -229.2K | 494.79K | -146.27K | 9.63K | -1.14M | -1.22M | -209.7K | 145.97K | -321.39K | -1.33M | -1.89M | -2.43M | -82.41K | -342.35K |
Other Non-Cash Items | 13.79B | 13.79B | 1.25B | 11.48M | 11.06M | 11.91M | 2.86M | 1.64M | 483.64K | 1.4M | 1.22M | 904.89K | 2.06M | 265.92K | 265.92K | 304.69K | -404.87K | -3.81M | -3.79M | -3.44M | -1.63M | 1.51M |
Deferred Income Tax | 457.38M | 457.38M | 226.07M | n/a | n/a | n/a | n/a | n/a | 1.15M | -904.89K | -904.89K | -904.89K | -2.06M | -265.92K | -265.92K | -265.92K | -265.92K | n/a | 3.98M | 3.98M | 3.98M | 3.98M |
Change in Working Capital | 2.81M | 2.59M | 15.69K | 617.46K | -1.66M | 128.74K | -351.48K | -3.32M | -133.97K | -2.06M | -1.08M | 1.9M | 372.75K | 1.91M | 1.31M | 1.45M | 897.29K | -74.72K | 396.7K | -550.41K | 372.19K | 201.27K |
Operating Cash Flow | -4.99B | -4.99B | -19.52M | -14.52M | -14.35M | -12.5M | -13.34M | -15.85M | -15.45M | -17.5M | -18.07M | -16.43M | -17.35M | -16.33M | -15.76M | -13.34M | -12.76M | -9.55M | -6.13M | -4.78M | -1.07M | -996.99K |
Capital Expenditures | -6.66K | -6.66K | -6.66K | -498 | -13.37K | -17.93K | -21.76K | -21.26K | -13K | -26.55K | -35.61K | -63.82K | -59.22K | -83.16K | -100.92K | -158.43K | -229.98K | -210.17K | -254.82K | -169.09K | -97.54K | -75.3K |
Cash Acquisitions | 2.22K | 2.22K | 2.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 3K | n/a | n/a | n/a |
Investing Cash Flow | -4.44K | -4.44K | -4.44K | -500 | -13.37K | -17.93K | -21.76K | -21.26K | -13K | -26.55K | -35.61K | -63.82K | -59.22K | -83.16K | -100.92K | -155.43K | -226.98K | -207.18K | -251.82K | -169.09K | -97.54K | -75.3K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 190K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.73B | -1.73B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.75B | 1.75B | 22.67M | -455.73K | n/a | n/a | n/a | n/a | 135.8K | n/a | n/a | 225.82K | -135.8K | 5.98K | 5.98K | -210.35K | -13.8K | 141.09K | 9.49K | -12.43K | -44.22K | -205.08K |
Financial Cash Flow | 22.67M | 22.67M | 31.52M | 15.48M | 18.38M | 19.17M | 16.4M | 10.3M | 15.24M | 20.82M | 15.91M | 15.16M | 7.54M | 1.19M | 11.97K | -204.36K | 26.36M | 26.52M | 26.38M | 26.36M | -40.58K | -15.08K |
Net Cash Flow | -4.97B | -4.97B | 12M | 959.96K | 4.02M | 6.66M | 3.04M | -5.58M | -217.92K | 3.29M | -2.2M | -1.34M | -9.87M | -15.23M | -15.86M | -13.71M | 13.36M | 16.75M | 20M | 21.4M | -1.21M | -1.09M |
Free Cash Flow | -4.99B | -4.99B | -19.52M | -14.52M | -14.36M | -12.51M | -13.36M | -15.87M | -15.46M | -17.52M | -18.11M | -16.49M | -17.41M | -16.41M | -15.86M | -13.5M | -12.99M | -9.76M | -6.38M | -4.95M | -1.17M | -1.07M |
Adj. Free Cash Flow | -4.89B | -4.9B | 76.03M | -14.85M | -14.89M | -13.04M | -13.73M | -16.08M | -15.85M | -18.09M | -18.84M | -17.35M | -17.98M | -16.9M | -16.26M | -13.81M | -13.19M | -9.86M | -6.47M | -5.01M | -1.26M | -1.17M |
Maintenance CapEx | -6.67K | -6.67K | -6.66K | -504 | -13.37K | -17.93K | -21.76K | -21.26K | -13K | -26.55K | -35.61K | -63.82K | -59.22K | -63.81K | -72.51K | -73.29K | -80.82K | -62.82K | -42.47K | -13.48K | -5.95K | -1.26K |
Growth CapEx | 6 | 6 | 6 | 6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.35K | -28.4K | -85.14K | -149.16K | -147.35K | -212.35K | -155.61K | -91.59K | -74.05K |
Owner Earnings | -4.99B | -4.99B | -19.52M | -14.52M | -14.36M | -12.51M | -13.36M | -15.87M | -15.46M | -17.52M | -18.11M | -16.49M | -17.41M | -16.39M | -15.84M | -13.42M | -12.85M | -9.62M | -6.17M | -4.8M | -1.08M | -998.25K |
Add to Watchlist
Select watchlists to add or remove RNAZ